The 36-month beta value for QIPT is also noteworthy at 1.10. There are mixed opinions on the stock, with 0 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”
The public float for QIPT is 40.65M, and at present, short sellers hold a 1.43% of that float. The average trading volume of QIPT on May 24, 2024 was 185.01K shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
QIPT) stock’s latest price update
Quipt Home Medical Corp (NASDAQ: QIPT) has seen a decline in its stock price by -0.16 in relation to its previous close of 3.13. However, the company has experienced a -0.79% decline in its stock price over the last five trading sessions. seekingalpha.com reported 2024-05-16 that Quipt Home Medical Corp. (NASDAQ:QIPT ) Q2 2024 Earnings Conference Call May 16, 2024 10:00 AM ET Company Participants Greg Crawford – Chairman, CEO Hardik Mehta – CFO Conference Call Participants Richard Close – Canaccord Genuity Douglas Cooper – Beacon Securities Justin Keywood – Stifel Bill Sutherland – The Benchmark Company Rahul Sarugaser – Raymond James Operator Thank you for standing by. This is the conference operator.
QIPT’s Market Performance
Quipt Home Medical Corp (QIPT) has seen a -0.79% fall in stock performance for the week, with a -14.62% decline in the past month and a -26.64% plunge in the past quarter. The volatility ratio for the week is 6.43%, and the volatility levels for the past 30 days are at 4.98% for QIPT. The simple moving average for the past 20 days is -15.43% for QIPT’s stock, with a -32.68% simple moving average for the past 200 days.
Analysts’ Opinion of QIPT
Canaccord Genuity gave a rating of “Buy” to QIPT, setting the target price at $11 in the report published on June 14th of the previous year.
QIPT Trading at -19.72% from the 50-Day Moving Average
After a stumble in the market that brought QIPT to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -48.05% of loss for the given period.
Volatility was left at 4.98%, however, over the last 30 days, the volatility rate increased by 6.43%, as shares sank -14.62% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -22.46% lower at present.
During the last 5 trading sessions, QIPT fell by -0.79%, which changed the moving average for the period of 200-days by -39.56% in comparison to the 20-day moving average, which settled at $3.67. In addition, Quipt Home Medical Corp saw -38.61% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for QIPT
Current profitability levels for the company are sitting at:
- 0.03 for the present operating margin
- 0.64 for the gross margin
The net margin for Quipt Home Medical Corp stands at -0.02. The total capital return value is set at 0.04. Equity return is now at value -4.49, with -1.82 for asset returns.
Based on Quipt Home Medical Corp (QIPT), the company’s capital structure generated 0.43 points at debt to capital in total, while cash flow to debt ratio is standing at 0.51. The debt to equity ratio resting at 0.77. The interest coverage ratio of the stock is 0.9.
Currently, EBITDA for the company is 55.25 million with net debt to EBITDA at 1.4. When we switch over and look at the enterprise to sales, we see a ratio of 0.86. The receivables turnover for the company is 7.79for trailing twelve months and the total asset turnover is 1.02. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.14.
Conclusion
In summary, Quipt Home Medical Corp (QIPT) has had a bad performance as of late. Analysts have mixed opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
